Atomwise Company

Atomwise uses artificial intelligence for drug discovery. We design new molecules for the hardest targets. Our discoveries help our partners deliver better medicines faster.


Connections from

Total Funding: 176645000.0
Headquarters: United
Funding Status: Early Stage Venture
Employee Number: 94
Estimated Revenue: 2.3
Last Funding Type: Grant
Technology: ['BioTech & HealthTech']
Investor Type: For Profit
Last Funding Date: 2020-10-06
Investors Number: 22.0
Founded Date: 2012-01-01
Industry: Application Software